Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Bmy Stock

Finance    Medium opportunity   

  

Track this trend
(Monitor this trend over time)
 12 Months
Average: 64.9%
Trend: declining
MOM change: -0.12%
 5 Years
Average: 38.05%
Trend: growing
MOM change: 1.82%

Latest forum discussions

We tracked 108 total in the last 3 months

... of BMY today as I continue to reduce my holdings to diversify my stock... in the profits from the stock's impressive run the past ...+ months I'll replace the BMY with other blue chips that ... my first pick Still own BMY stock that is the basis for ... trim. Hope this helps the stock go higher for all my ...
Published on 2022-04-20 in the BMY forum
This discussion is in English.
It was sarcasm. My using the word prophetic obviously didnt translate. Typical Cordari, he was whining about BMY. The stock bottomed on 11/30, the exact day he was calling for low 40's. Cordari has not made a post since that day with the stock rallying 37%.
Published on 2022-03-28 in the BMY forum
This discussion is in English.
It was sarcasm. My using the word prophetic obviously didnt translate. Typical Cordari, he was whining about BMY. The stock bottomed on 11/30, the exact day he was calling for low 40's. Cordari has not made a post since that day with the stock rallying 37%.
Published on 2022-03-28 in the BMY forum
This discussion is in English.
BMY announced plans to buy CELG ... 3Q2017 earnings presentation cratered CELG stock. WELCOME TO THE CELGENE CORPORATION... certain purchasers of Celgene common stock and your rights with respect... entities who purchased the common stock of Celgene between April 27... your transactions in Celgene common stock during the Class Period). You...
Published on 2022-06-22 in the BMY forum
This discussion is in English.
BMY announced plans to buy CELG ... 3Q2017 earnings presentation cratered CELG stock. WELCOME TO THE CELGENE CORPORATION... certain purchasers of Celgene common stock and your rights with respect... entities who purchased the common stock of Celgene between April 27... your transactions in Celgene common stock during the Class Period). You...
Published on 2022-06-22 in the BMY forum
This discussion is in English.
... as binary in terms of stock implications, as we wouldremain positive...-like label for deucravacitinib). For BMY,we also expect commentary relating ... year. ... We continue to favor BMY shares, with our Buy rating ... has been unchanged. On Milvexian, BMY/JNJ have discussed they will ... at the end of February, BMY reiterated that with Abecma the ... We are Buy rated on BMY. Our 12-month price target ...
Published on 2022-04-14 in the BMY forum
This discussion is in English.
... as binary in terms of stock implications, as we wouldremain positive...-like label for deucravacitinib). For BMY,we also expect commentary relating ... year. ... We continue to favor BMY shares, with our Buy rating ... has been unchanged. On Milvexian, BMY/JNJ have discussed they will ... at the end of February, BMY reiterated that with Abecma the ... We are Buy rated on BMY. Our 12-month price target ...
Published on 2022-04-14 in the BMY forum
This discussion is in English.
... fairly insignificant amount in XOM, BMY, and VZ. These are the... dividend yields in March 2020. BMY is a former employer, and...’t per se buy that stock*, but again, the dividend on... match in the form of BMY stock, for which they were sued ...
Published on 2022-05-04 in the In My Humble Opinion (IMHO) forum
This discussion is in English.
... fairly insignificant amount in XOM, BMY, and VZ. These are the... dividend yields in March 2020. BMY is a former employer, and...’t per se buy that stock*, but again, the dividend on... match in the form of BMY stock, for which they were sued ...
Published on 2022-05-04 in the In My Humble Opinion (IMHO) forum
This discussion is in English.
Now that BMY's stock price has exceeded its 12 month analyst consensus PT estimate of $76.21 on Yahoo Finance, is BMY's stock presently overvalued and a sell ? The Nektar flop doesn't help matters. I prefer small cap biopharma that has 100-fold long-term upside potential, with many near-term positive catalysts. Best wishes to all
Published on 2022-04-16 in the Bristol-Myers Squibb Company (BMY) forum
This discussion is in English.
Now that BMY's stock price has exceeded its 12 month analyst consensus PT estimate of $76.21 on Yahoo Finance, is BMY's stock presently overvalued and a sell ? The Nektar flop doesn't help matters. I prefer small cap biopharma that has 100-fold long-term upside potential, with many near-term positive catalysts. Best wishes to all
Published on 2022-04-16 in the Bristol-Myers Squibb Company (BMY) forum
This discussion is in English.
BMY: Adam Lenkowsky, SVP and GM, ... there by recommendation and the stock has been amongst the most ...
Published on 2022-06-21 in the BMY forum
This discussion is in English.
BMY: Adam Lenkowsky, SVP and GM, ... there by recommendation and the stock has been amongst the most ...
Published on 2022-06-21 in the BMY forum
This discussion is in English.
You have to assume BMY is very interested in taking ... against Astra Zeneca and Glaxo. BMY can easily make strong market... target to the cancer tumors. BMY has been struggling with revenue... moving into CLVS and that stock went from $5, into the ...
Published on 2022-04-03 in the Clovis Oncology, Inc. (CLVS) forum
This discussion is in English.
You have to assume BMY is very interested in taking ... against Astra Zeneca and Glaxo. BMY can easily make strong market... target to the cancer tumors. BMY has been struggling with revenue... moving into CLVS and that stock went from $5, into the ...
Published on 2022-04-03 in the Clovis Oncology, Inc. (CLVS) forum
This discussion is in English.
...)-- Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc... of Turning Point Therapeutics’ common stock at a price of $76... of Turning Point Therapeutics’ common stock and the expiration or termination...
Published on 2022-06-03 in the BMY forum
This discussion is in English.
...)-- Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc... of Turning Point Therapeutics’ common stock at a price of $76... of Turning Point Therapeutics’ common stock and the expiration or termination...
Published on 2022-06-03 in the BMY forum
This discussion is in English.
.... BMY paid Nektar 1 billion upfront, bought 850 million in Nektar stock... a 40/40 split with BMY that would be worth over...
Published on 2022-04-15 in the Clovis Oncology, Inc. (CLVS) forum
This discussion is in English.
.... BMY paid Nektar 1 billion upfront, bought 850 million in Nektar stock... a 40/40 split with BMY that would be worth over...
Published on 2022-04-15 in the Clovis Oncology, Inc. (CLVS) forum
This discussion is in English.